MetaCap

Aytu BioPharma Insider Trades

NASDAQ: AYTUHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.03-0.025 (-1.22%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

Aytu BioPharma insider activity

Over the last 12 months, Aytu BioPharma insiders reported 8 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows PYSZCZYMUKA GREG (Chief Commercial Officer) reporting a transaction in 20,000 shares on Jul 28, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put AYTU's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

AYTU insider transactions

Aytu BioPharma insider transactions
DateInsiderTypeSharesValueFiling
Jul 28, 2026Donofrio John Jr.DirectorAward10,000—Form 4
Jul 28, 2026DOCKERY CARLDirectorAward10,000—Form 4
Jul 28, 2026JAIN ABHINAVDirectorAward10,000—Form 4
Jul 28, 2026LIU VIVIAN HDirectorAward10,000—Form 4
Jul 28, 2026Selhorn Ryan JChief Financial OfficerAward25,000—Form 4
Jul 28, 2026Disbrow JarrettChief Business OfficerAward15,000—Form 4
Jul 28, 2026Disbrow Joshua R.Chief Executive OfficerAward30,000—Form 4
Jul 28, 2026PYSZCZYMUKA GREGChief Commercial OfficerAward20,000—Form 4
Oct 3, 2025DOCKERY CARLDirectorAward10,000—Form 4
Oct 3, 2025LIU VIVIAN HDirectorAward10,000—Form 4
Oct 3, 2025Selhorn Ryan JChief Financial OfficerAward17,500—Form 4
Oct 3, 2025Selhorn Ryan JChief Financial OfficerAward16,243—Form 4
Oct 3, 2025Donofrio John Jr.DirectorAward10,000—Form 4
Oct 3, 2025Disbrow JarrettChief Business OfficerAward12,500—Form 4
Oct 3, 2025Disbrow JarrettChief Business OfficerAward19,606—Form 4
Oct 3, 2025JAIN ABHINAVDirectorAward10,000—Form 4
Oct 3, 2025PYSZCZYMUKA GREGChief Commercial OfficerAward12,500—Form 4
Oct 3, 2025Disbrow Joshua R.Chief Executive OfficerAward22,500—Form 4
Oct 3, 2025Disbrow Joshua R.Chief Executive OfficerAward31,446—Form 4
Jun 9, 2025Disbrow Joshua R.Chief Executive OfficerBuy66,666$100.00KForm 4
Jun 9, 2025Disbrow JarrettChief Business OfficerBuy16,666$25.00KForm 4
Mar 31, 2025PYSZCZYMUKA GREGChief Commercial OfficerOption exercise209—Form 4
Feb 28, 2025Disbrow Joshua R.Chief Executive OfficerBuy15,000$19.50KForm 4
Feb 5, 2025Selhorn Ryan JChief Financial OfficerOption exercise105—Form 4
Dec 31, 2024PYSZCZYMUKA GREGChief Commercial OfficerOption exercise208—Form 4
Nov 11, 2024Selhorn Ryan JChief Financial OfficerAward14,000—Form 4
Nov 6, 2024LIU VIVIAN HDirectorAward1,500—Form 4
Nov 6, 2024JAIN ABHINAVDirectorAward1,500—Form 4
Nov 6, 2024Donofrio John Jr.DirectorAward1,500—Form 4
Nov 6, 2024DOCKERY CARLDirectorAward1,500—Form 4
Sep 30, 2024PYSZCZYMUKA GREGChief Commercial OfficerOption exercise209—Form 4
Jun 30, 2024PYSZCZYMUKA GREGChief Commercial OfficerOption exercise208—Form 4
Mar 31, 2024PYSZCZYMUKA GREGChief Commercial OfficerOption exercise208—Form 4
Dec 31, 2023PYSZCZYMUKA GREGChief Commercial OfficerOption exercise209—Form 4
Sep 30, 2023PYSZCZYMUKA GREGChief Commercial OfficerOption exercise208—Form 4
Aug 16, 2023JAIN ABHINAVDirectorAward6,500—Form 4
Aug 11, 2023LIU VIVIAN HDirectorAward1,500—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related